Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cocrystal Pharma Inc (COCP)

Cocrystal Pharma Inc (COCP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 109,702
  • Shares Outstanding, K 68,564
  • Annual Sales, $ 6,560 K
  • Annual Income, $ -48,170 K
  • 60-Month Beta 1.38
  • Price/Sales 38.89
  • Price/Cash Flow 1.25
  • Price/Book 2.15
Trade COCP with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4700 +4.08%
on 03/03/21
2.2900 -33.19%
on 02/08/21
-0.3700 (-19.47%)
since 02/03/21
3-Month
1.2500 +22.40%
on 01/04/21
2.5400 -39.76%
on 01/20/21
-0.1100 (-6.71%)
since 12/03/20
52-Week
0.6000 +155.00%
on 03/25/20
3.0400 -49.67%
on 08/04/20
+0.3800 (+33.04%)
since 03/03/20

Most Recent Stories

More News
Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference [UPDATED]

Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery...

COCP : 1.5300 (-4.38%)
Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery...

COCP : 1.5300 (-4.38%)
Cocrystal Pharma (COCP) Jumps: Stock Rises 7.3%

Cocrystal Pharma (COCP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

BPMC : 93.02 (-5.84%)
COCP : 1.5300 (-4.38%)
Cocrystal Pharma Presentation at the reimagine Health Research Symposium Features Overview of Platform Technology and Four Antiviral Case Studies

Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery...

COCP : 1.5300 (-4.38%)
Cocrystal Pharma (COCP) Completes Research Obligations With Merck

Cocrystal (COCP) completes all research obligations under the Merck exclusive worldwide license and collaboration agreement.

ALXN : 148.19 (-1.45%)
MRK : 73.30 (+0.62%)
ACOR : 6.29 (+1.62%)
COCP : 1.5300 (-4.38%)
Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement

Program advances within the agreement's initial two-year timeframe

MRK : 73.30 (+0.62%)
COCP : 1.5300 (-4.38%)
Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium

Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery...

COCP : 1.5300 (-4.38%)
Cocrystal Pharma to Present at Virtual NobleCon17 Conference on January 19, 2021

Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics, announces that management will present...

COCP : 1.5300 (-4.38%)
Cocrystal Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics, announces management will present...

COCP : 1.5300 (-4.38%)
Thinking about buying stock in Gevo Inc, Inovio Pharmaceuticals, Odonate Therapeutics, Cocrystal Pharma, or Vuzix Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, INO, ODT, COCP, and VUZI.

COCP : 1.5300 (-4.38%)
INO : 9.56 (-4.59%)
ODT : 18.73 (-1.94%)
GEVO : 8.25 (-10.91%)
VUZI : 20.26 (-10.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise...

See More

Key Turning Points

3rd Resistance Point 1.8267
2nd Resistance Point 1.7433
1st Resistance Point 1.6367
Last Price 1.5300
1st Support Level 1.4467
2nd Support Level 1.3633
3rd Support Level 1.2567

See More

52-Week High 3.0400
Fibonacci 61.8% 2.1079
Fibonacci 50% 1.8200
Fibonacci 38.2% 1.5321
Last Price 1.5300
52-Week Low 0.6000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar